$504 Million is the total value of Rhenman & Partners Asset Management AB's 92 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACHN | Achillion Pharmaceuticals Inc | $2,054,000 | -28.4% | 266,000 | 0.0% | 0.41% | -6.0% | |
| TNDM | Tandem Diabetes Care Inc | $1,820,000 | -26.3% | 209,000 | 0.0% | 0.36% | -3.2% | |
| RGLS | Regulus Therapeutic Inc | $1,386,000 | -20.5% | 200,000 | 0.0% | 0.28% | +4.2% | |
| ARRY | Array BioPharma Inc | $1,092,000 | -30.0% | 370,000 | 0.0% | 0.22% | -8.1% | |
| MRTX | Mirati Therapeutics Inc | $1,070,000 | -32.3% | 50,000 | 0.0% | 0.21% | -11.3% | |
| AAVL | Avalanche Biotechnologies Inc | $796,000 | -45.7% | 154,006 | 0.0% | 0.16% | -28.8% | |
| BINDQ | BIND Therapeutics Inc | $294,000 | -3.9% | 133,535 | 0.0% | 0.06% | +26.1% | |
| THLD | Threshold Pharmaceuticals | $93,000 | -4.1% | 201,537 | 0.0% | 0.02% | +20.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-04-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.